WTO GPA- Support Behind Suppliers’ Back in Government Tender Disputes

Back in 1998, the Review Body on Bid Challenges was set up following the Agreement on Government Procurement under the World Trade Organization (WTO GPA), which enables Suppliers to guard themselves against unfair tendering practices by governmental procuring entities.

Below is a rough outline of a regular bid challenge:

  1. Supplier (Complainant) files a challenge upon noticing flaws in tender.
  2. Review Body rules if there is a prima facie case.
  3. Review Body rules on imposition of Rapid Interim Measures (RIM) (if requested by the Complainant).
  4. Review Body determines the dispute, recommends appropriate remedies and issues costs orders.

Nevertheless, the Review Body has rarely been invoked since its establishment. Until recently, a Health Care Supply Chain has successfully lodged the 9th valid challenge based on procedural impropriety, after a procuring entity rejected its requests for further explanation of the tender for the provision of medical apparatus.

The Review Body, as illustrated in this case, has certain features that make it effective in resolving breaches of WTO GPA by the Government.

1. INDEPENDENCE

The Review Body is free from any interference to ensure its unbiased position. In the latest challenge, while the Government opposed to the RIM requested by the Complainant to suspend the tender contract award on the ground of protecting public interests, the Review Body rejected this argument as it found potential damage to the public minimal compared to the importance of enshrining the core values of fairness and transparency promoted by the WTO GPA.

2. EXPEDITIOUS NATURE

The Review Body is also being applauded for its high efficiency. Typically, the Review Body rules on the validity of a bid challenge within 90 working days from the date of issuance of the notification of acceptance. Therefore, although the Government argued that the Review Body had discretion to extend the time up to 180 days, which could cause delay in procurement of essential hospital appliances, the Review Body again disagreed, saying that it would reach a decision without necessary delay.

3. RIM

As its name suggests, the Review Body may implement RIM to provide rapid and immediate relief to the Complainant in a defective procurement exercise. Since its implementation will be recommended within 10 working days after confirmation of a valid challenge, like what happened in the case, defects of the tender can be timely rectified and commercial interests of the Complainant preserved.

4. DIVERSE PANEL

If there exists a prima facie case, a panel will be appointed to the Review Body to conduct further investigation. Comprising of 12 professionals with various backgrounds, including law, technology and finance, the panel is capable of handling complainants filed by suppliers of different industries.

Still, there are some limitations in the Review Body’s operations:

a. PUBLIC HEARING ONLY UPON UNILATERAL CONSENT

Procedurally, the Review Body will conclude a challenge either through arranging actual private or public hearing, or considering written submissions.

Ironically, whilst WTO GPA values transparency (transparency and fairness being enshrined in its procedure), an open hearing will only be allowed upon the consent of BOTH parties.

Up to now, procuring entities have always invoked such technicality in order to avoid the risk of bad publicity. Given the circumstances (especially considering the prevailing culture in Hong Kong), procuring entities have virtually on every occasion simply opt to refuse to provide consent for a public hearing, undermining the ideals at roots of the Review Body. Whilst such attitude of procuring entities have often times attracted criticisms from presiding panels in question, this issue has yet to be overcome.

b. PUBLIC POLICY

The Government may rebut the prima facie case or implementation of RIM on the ground of overriding public benefits, making it difficult for Suppliers to lodge a valid challenge or seek any relief. We should nonetheless bear in mind that public policy is not an invincible shield, as shown in the above.

In the past, whilst procuring entities have on one occasion successfully opposed the implementation of RIM on the ground that delays in awarding contracts to pharmaceutical providers will cause disruption (i.e. medicine being consumable), in a more recent case the invocation of similar arguments when the tender is for hardware (i.e. there will not be automatic breakdown of equipment upon expiry of projected operating timeline), the Review Body will utilize its inherent authority to refuse the procuring entity’s opposition.

c. NO LEGALLY BINDING ORDERS

The biggest limitation of the Review Body is that it is only entitled to recommend but not enforce proper remedies. As such, even if a complainant is successful in every stage of the way, the procuring entity can still always simply refuse to implement the recommendations of the board.

Fortunately, every cloud has a silver lining: the decisions of the Review Body is subject to judicial review, and hence a favourable outcome to deserved Complainants is better guaranteed. Alas, however, the existing system leaves for much room for improvement.

Safeguarding fair and open competitions, especially those initiated by the government procuring entities, is always of the utmost importance in Hong Kong being an international business hub. It is therefore believed that the Review Body will continue to realize its greatest utility in resolving forthcoming bid challenges.

 

Hong Kong Lawyer & Law Lecturer, Director at CITD (HKEx 8178), Senior Consultant at Prosynergy, Co-Chair of Hong Kong Web3 Association and Legal Advisor at Women in Web3 Hong Kong

Joshua Chu is a qualified lawyer, law lecturer, and technology leader with a proven track record in predictive AIcybersecurity, and blockchain innovation. As Director at CITD (HKEx 8178), he drives advancements in AI and Web3 cybersecurity. He is also private practice solicitor, Senior Consultant at Prosynergy (a regulatory consulting firm led by former SFC regulators), and Law Lecturer at HKUSPACE.

Recognised by the industry, Joshua also serves as the Co-Chair of The Hong Kong Web3 AssociationDirector at the Corporate Counsel Hong Kong Association, and Legal Advisor to both Women in Web3 Hong Kong and the Hong Kong Blockchain Association

Over the years, Joshua has spearheaded a number of groundbreaking cases, including:

[a] Hong Kong’s first crypto litigation in Bitmain Technologies Limited v iFinex Inc. & Anor. HCA 1980/2015 (2016),

[b] Hong Kong’s first court order for service via data room in in Hwang Joon Sang & Anor v G.E.I & Ors[2020] HKCFI 1084 and [2020] HKCFI 1233 (2020),

[c] Hong Kong’s first tokenised Listed Company bonds (2023), 

[d] Co-Advocate in Hong Kong’s first civil judgment against JPEX in Chan Wing Yan and Anor. v. JP-EX Crypto Asset Platform Pty Ltd and Others  [2024] HKDC 1628 (2024, colloquially dubbed “Hong Kong’s FTX”), and

[e] Hong Kong’s first tokenised injunction order (2024).

Joshua regularly handles various international arbitration cases, asset recovery cases (both fiat and virtual), property development disputes, shareholders and employment disputes, investigations, and WTO GPA disputes.

Before his legal career, Joshua led the IT department at Evangel Hospital, bringing a unique multidisciplinary perspective to his work. This background has empowered him to develop innovative legal and technological solutions, effectively tackling complex issues that arise in cases involving emerging technologies such as AI, blockchain, and cybersecurity.

His cases and achievements have been regularly featured in both international and local media alike and is also the recipient of various In-House Counsel Awards in the fields of Data & Cloud Technologies, Litigation, Risks & Compliance. 

 

Partner, Ravenscroft & Schmierer, Hong Kong

Anna is a Hong Kong qualified lawyer and is responsible as a partner at Ravenscroft & Schmierer for the commercial litigation department. Aside from her legal background, Anna is also an advisor to the Ohkims Blockchain Centre in South Korea and Hong Kong qualified lawyer and a regulatory consultant specialized in IT control and compliance.  

Before starting her practice as a lawyer, Anna worked closely with the United States Patent and Trademark Office (USPTO) and US Food and Drug Administration (FDA) on intellectual property and FDA regulatory matters. 

​Since embarking on her legal career, Anna was part of the team that defended a party in Hong Kong High Court proceedings involving the jurisdiction’s first cryptocurrency cases where she leveraged her science and engineering skills extensively to help improve her client’s case’s position. This feat was repeated again shortly after when Anna again leveraged her science background in a healthcare-related tender dispute. 

​Today, Anna is proactively working on various Distributed Ledger Technology related projects where she combines her love for science and technology together with the logic behind regulatory framework.